AXL and tongue cancer: To this end, SCC-25 cells derived from a primary tongue cancer [21] with low endogenous AXL protein expression and HN cells derived from a lymph node metastasis [22] with high endogenous AXL protein expression (Figure 3A) were treated with BGB324.